To mark the 40th Foundation Day of the Department of Biotechnology (DBT) today, Union Minister of State (Independent Charge) ...

Researchers at the Department of Chemical Engineering and Biotechnology (CEB) have found a new way to organize molecules inside living cells, opening possibilities for more controlled and efficient ...

Study represents a significant advancement in Grove’s Bionic Biologics™ platform – CHICAGO--(BUSINESS WIRE)--February 24, 2026-- Grove Biopharma, ...

Advanced Micro Devices rallies after the chip maker unveils a multiyear deal to supply computing power to Meta Platforms.

Vir stock catapulted Tuesday after the small biotech company smashed fourth-quarter sales views and signed a deal with Astellas Pharma.

The central question is no longer whether we can innovate, but whether innovation can truly reach patients in time.

Novo’s answer to a closely watched Lilly drug spurred roughly 20% weight loss after 24 weeks in a Phase 2 trial, results one of its executives claimed to be “differentiating.” ...

Fresh off a failed trial that sent its shares plummeting, Novo Nordisk said that one of its experimental obesity drugs helped patients lose nearly 20% of their weight after 24 weeks in a midstage tria ...

UBT251 "triple G" obesity drug posts 19.7% weight loss vs 2.0% placebo in a mid-stage China trial after 24 weeks.

Larimar on Tuesday said nomlabofusp, a protein replacement therapy that is being developed as a potential treatment for Friedreich's ataxia, was granted the important designation that is designed to ...